DnB Asset Management’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-29,700
Closed -$1.49M 672
2021
Q3
$1.49M Buy
+29,700
New +$1.62M 0.01% 579

Other funds holding HCAT

DnB Asset Management's HCAT Position: Q4 2021 in Review

DnB Asset Management sold out of Health Catalyst (HCAT) in Q4 2021, closing a stake of 29,700 shares — an estimated $1.49M sold.

DnB Asset Management first reported a position in HCAT in Q3 2021 and held it in 1 quarter. The position peaked at $1.49M in Q3 2021. 186 funds tracked by Wall St. Rank hold HCAT as of Q4 2021.

  • DnB Asset Management reported no remaining Health Catalyst position as of Q4 2021 after selling out during the quarter.
  • DnB Asset Management sold 29,700 Health Catalyst shares in Q4 2021, an estimated $1.49M.
  • DnB Asset Management first reported a position in Health Catalyst in Q3 2021 and held it in 1 quarter.
  • DnB Asset Management's Health Catalyst position peaked at $1.49M in Q3 2021.
  • 186 funds tracked by Wall St. Rank held Health Catalyst as of Q4 2021.

Based on DnB Asset Management's 13F filing for Q4 2021, filed 12 Jan 2022.